Maxpharma SA

1.9 FTE

Company number (CBE) 0471.830.863 · VAT BE0471830863

1040 Etterbeek

active in Retail sale of pharmaceutical products (NACE 47730)

operating since 05 May 2000 (≈ 26 yrs)

Ask Idonis

＋ Add to a list Export to Excel Pro

Public Public page: latest year only. The score, history and details open with a free account. Create a free account

Idonis solidity score

EDCBA

The score of Maxpharma shows with a free account.

See the score

Profile

SA Micro · 1.9 FTE since 2000

Components

Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register

Position in its sectorvs peers
Supplier creditat 30 d
Borrowing capacityborrowable
Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result15,264 €

Equity284,725 €

Cash118,091 €

EBITDA43,394 €

Total assets426,986 €

Headcount (avg FTE)1.9

Solvency66.7%

The line marks its sector median: 37.8% (349 companies).

Change 2022 → 2025: Equity -11 % Total assets -14 % Headcount (avg FTE) -17 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Maxpharma's annual accounts

	2025	2024	2023	2022	2021
Net result	15,264 €
Equity	284,725 €
Cash	118,091 €
EBITDA	43,394 €
Total assets	426,986 €

See all 10 years Export to Excel Pro

Filed annual accounts

Year ended 31 Dec 2025filed on 01 Jul 2026
Year ended 31 Dec 2024filed on 24 Jul 2025
Year ended 31 Dec 2023filed on 23 Aug 2024
Year ended 31 Dec 2022filed on 30 Aug 2023
Year ended 31 Dec 2021filed on 13 Jul 2022

Maxpharma's financial analysis

Open the full analysis

Management and control of Maxpharma

3 active director(s) in the register.

Maxpharma's shareholders and holdings →

See the directors and their mandates

Maxpharma's publications in the Belgian Gazette

Read the publications in detail

Company number, VAT number and registered office

Company number (CBE): 0471.830.863
VAT number: BE0471830863
Peppol: Registered · 0208:0471830863 · as of 02 Nov 2026
Legal form: SA
Incorporated: 05 May 2000
Registered office: 1040 Etterbeek
Size: Micro · 1.9 FTE
Latest accounts: 2025 · filed on 01 Jul 2026
Activity: Retail sale of pharmaceutical products (NACE 47730)

Maxpharma (SA) has been based in Etterbeek since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 15,264 € and equity of 284,725 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 66.7%, above the median of its sector (37.8%).

Companies similar to Maxpharma

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Maxpharma

What is the revenue of Maxpharma?

Maxpharma files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Maxpharma?

In Belgium, the VAT number is the company number prefixed with BE: BE0471830863 for Maxpharma, if the company is VAT-registered. Its company number (CBE) is 0471.830.863.

Where is the registered office of Maxpharma?

According to the CBE register, the registered office of Maxpharma is in 1040 Etterbeek.

What is the equity of Maxpharma?

At the close of the 2025 financial year, the equity of Maxpharma amounts to 284,725 €, a solvency of 66.7% of total assets.

How many people work at Maxpharma?

1.9 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Maxpharma?

The register lists 3 active mandates at Maxpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Maxpharma

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →

Free account in 30 seconds, by email. No bank card.

Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗

	Free	Pro	Enterprise
Ask
Analyses per month	≈ 6	≈ 160	≈ 100 per user, pooled
Credit packs (no expiry)	✓	✓	✓
Unit of account	Your account is debited in credits: one analysis ≈ 25 credits, a pack of 1 000 credits ≈ 40 analyses. The exact balance is in your account, the cost of each answer under it.
The company file
Search by name, CBE number or address	✓	✓	✓
Identity, activity, legal status, published mandates	✓	✓	✓
Idonis Score explained (formula and values)	✓	✓	✓
Annual accounts	last 2 financial years	every filed year	every filed year
Ratios	5 basic	all, with provenance	all, with provenance
Indicative supplier credit and borrowing capacity	—	✓	✓
Estimates (revenue, margins, cash flow)	—	✓	✓
Sector positioning on the company file	—	✓	✓
Indicative valuation (range)	—	✓	✓
Deeds published in the Belgian Gazette	last 12 months	full published history	full published history
Follow
Company lists	1 list of 5	multiple lists	multiple · shared
Dashboard signals (filings, Gazette, score)	✓	✓	✓
E-mail alerts	—	✓	✓
Import of a list of company numbers	—	✓	✓
Understand
Explorer: filters, map	50 results	200 per page	200 per page
Sector pages (medians, comparison)	✓	✓	✓
Excel export (auditable formulas)	—	✓	✓
Network
Directors, mandates and people	—	✓	✓
Ownership graph	1 hop	multi-hop, as of a date	multi-hop, as of a date
Team
Users, admin console, usage per person	—	—	✓
Pooled credits, single invoice	—	—	✓
Shared lists	—	—	✓
Integration
API	—	—	optional
Idonis inside your own AI (MCP)	—	—	optional